BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30317464)

  • 1. Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients.
    Suzuki E; Sugimoto M; Kawaguchi K; Pu F; Uozumi R; Yamaguchi A; Nishie M; Tsuda M; Kotake T; Morita S; Toi M
    Breast Cancer; 2019 May; 26(3):282-289. PubMed ID: 30317464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer.
    Kawaguchi K; Suzuki E; Yamaguchi A; Yamamoto M; Morita S; Toi M
    Breast Cancer; 2017 Jan; 24(1):111-120. PubMed ID: 26942414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAV gene expression in PBMCs and TILs in patients with breast cancer analyzed by a DNA melting curve (FQ-PCR) technique for TCR α chain CDR3 spectratyping.
    He XY; Yang WM; Tang WT; Ma R; Sun YP; Wang P; Yao XS
    Neoplasma; 2012; 59(6):693-9. PubMed ID: 22862170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering transcriptome profiles of peripheral blood mononuclear cells in response to PRRSV vaccination in pigs.
    Islam MA; Große-Brinkhaus C; Pröll MJ; Uddin MJ; Rony SA; Tesfaye D; Tholen E; Hölker M; Schellander K; Neuhoff C
    BMC Genomics; 2016 Aug; 17(1):641. PubMed ID: 27528396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into significant pathways and gene interaction networks in peripheral blood mononuclear cells for early diagnosis of hepatocellular carcinoma.
    Jiang JX; Yu C; Li ZP; Xiao J; Zhang H; Chen MY; Sun CY
    J Cancer Res Ther; 2016; 12(2):981-9. PubMed ID: 27461685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune signature of metastatic breast cancer: Identifying predictive markers of immunotherapy response.
    Kim JY; Lee E; Park K; Park WY; Jung HH; Ahn JS; Im YH; Park YH
    Oncotarget; 2017 Jul; 8(29):47400-47411. PubMed ID: 28537889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating factor analysis and a transgenic mouse model to reveal a peripheral blood predictor of breast tumors.
    LaBreche HG; Nevins JR; Huang E
    BMC Med Genomics; 2011 Jul; 4():61. PubMed ID: 21781289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Expression Profile of Peripheral Blood Mononuclear Cells in Response to Intracerebral Hemorrhage.
    Sang M; Wang X; Zhang H; Sun X; Ding X; Wang P; Jiao R; Cheng H; Yang S; Zhang G
    DNA Cell Biol; 2017 Aug; 36(8):647-654. PubMed ID: 28654306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects.
    Barati M; Sinaeian M; Shokrollahi Barough M; Pak F; Semnani V; Kokhaei P; Momtazi-Borojeni AA
    J Interferon Cytokine Res; 2020 Mar; 40(3):139-144. PubMed ID: 31905037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the nCounter Analysis System to Monitor Immune-related Biomarkers in PBMCs During Anti-PD-1 Therapy.
    Morisaki T; Kubo M; Umebayashi M; Yuan Y; Tsuyada A; Tanaka H; Koya N; Nakagawa S; Morisaki T; Nakamura M
    Anticancer Res; 2019 Aug; 39(8):4517-4523. PubMed ID: 31366554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer.
    Vudattu NK; Magalhaes I; Schmidt M; Seyfert-Margolis V; Maeurer MJ
    Int J Cancer; 2007 Oct; 121(7):1512-9. PubMed ID: 17546596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients.
    Dewan MZ; Takada M; Terunuma H; Deng X; Ahmed S; Yamamoto N; Toi M
    Biomed Pharmacother; 2009 Nov; 63(9):703-6. PubMed ID: 19269774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Regulatory T Cell-Related Markers (FOXP3, CTLA-4 and GITR) by Peripheral Blood Mononuclear Cells from Patients with Breast Cancer.
    Khalife E; Khodadadi A; Talaeizadeh A; Rahimian L; Nemati M; Jafarzadeh A
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3019-3025. PubMed ID: 30484986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis.
    Edwards CJ; Feldman JL; Beech J; Shields KM; Stover JA; Trepicchio WL; Larsen G; Foxwell BM; Brennan FM; Feldmann M; Pittman DD
    Mol Med; 2007; 13(1-2):40-58. PubMed ID: 17515956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional up-regulation of BMP-4 and BMPR-II genes in the peripheral blood of breast cancer patients: A pilot study.
    Gul S; Murad S; Ehsan N; Bloodsworth P; Sultan A; Faheem M
    Cancer Biomark; 2015; 15(5):551-7. PubMed ID: 26406943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression analysis of peripheral blood cells reveals Toll-like receptor pathway deregulation in colorectal cancer.
    Xu Y; Xu Q; Yang L; Liu F; Ye X; Wu F; Ni S; Tan C; Cai G; Meng X; Cai S; Du X
    PLoS One; 2013; 8(5):e62870. PubMed ID: 23650534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc-Gamma receptor polymorphism and gene expression of peripheral blood mononuclear cells in patients with HER2-positive metastatic breast cancer receiving single-agent trastuzumab.
    Shimizu C; Mogushi K; Morioka MS; Yamamoto H; Tamura K; Fujiwara Y; Tanaka H
    Breast Cancer; 2016 Jul; 23(4):624-32. PubMed ID: 25962696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer.
    Mishra S; Srivastava AK; Suman S; Kumar V; Shukla Y
    Cancer Lett; 2015 Dec; 369(1):67-75. PubMed ID: 26276721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients.
    Suzuki E; Kataoka TR; Hirata M; Kawaguchi K; Nishie M; Haga H; Toi M
    BMC Cancer; 2015 Feb; 15():39. PubMed ID: 25655677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.